Terumo Aortic
Committed to Aortic Care. Together with our customers, we strive to create effective management of aortic disease and drive the evolution of our cardiovascular solutions for our patients.
This is the official VuMedi channel of Terumo Aortic. It is only intended for medical professionals and is not a substitute for ...
read more ↘ medical advice nor promotion of any medical procedure or product. Please be advised that not all of our products shown on this channel are registered in, approved for sale in, or available for purchase in, all countries or regions where this channel is accessible.
↖ read less
This is the official VuMedi channel of Terumo Aortic. It is only intended for medical professionals and is not a substitute for ...
read more ↘ medical advice nor promotion of any medical procedure or product. Please be advised that not all of our products shown on this channel are registered in, approved for sale in, or available for purchase in, all countries or regions where this channel is accessible.
↖ read less
Playback speed
10 seconds
One Year Results from the Thoraflex Hybrid US IDE Trial: Breakthrough
By
Terumo Aortic
FEATURING
S. Chris Malaisrie
By
Terumo Aortic
FEATURING
S. Chris Malaisrie
117 views
June 14, 2021
Chris Malaisrie presents on the results of the Thoraflex Hybrid US IDE Trial, including; an overview of worldwide published outcomes, technical experiences from the US IDE trial and the related 30-day outcomes.
The content, discussion and opinions expressed in this video are those of the physician and may not be reflective of the approved indications for use of the device, which may also differ by region. Please consult eifu.terumoaortic.com for product indications, contraindications and warnings/precautions.
Endovascular
Wed, Feb 9, 2022
Faculty: Piotr Szopiński , Robin Heijmen , Martin Funovics , Terumo Aortic , Bartosz Rylski
Faculty: Piotr Szopiński , Robin Heijmen , Martin Funovics , Terumo Aortic , Bartosz Rylski